Johnson and Johnson 2013 Settlement and Corporate Integrity Agreement
On November 4, 2013, the Department of Justice (DOJ) announced that Johnson & Johnson (J&J) and its pharmaceutical subsidiaries signed settlement agreements to pay more than $2.2 billion to resolve criminal and civil investigations into unapproved, or "off-label," promotion of three drugs and alleged kickbacks to physicians and nursing home pharmacies over a ten-year period. In 2012, we reported on the largest health care fraud settlement in U.S. history: $3 billion paid by GlaxoSmithKline.
According to the Associated Press, the J&J global settlement is the third-largest health care fraud settlement in U.S. history, and it includes a five-year Corporate Integrity Agreement (CIA) between J&J and the Department of Health and Human Services Office of the Inspector General (HHS-OIG). Key implications of the CIA for continuing medical education and compliance managers are outlined below.
Summary of Criminal and Civil Agreements
The global resolution includes criminal fines and a forfeiture of profits totaling $485 million and civil settlements arising under the False Claims Act totaling $1.72 billion, paid out to federal and state governments as reimbursement for improper Medicaid payments.
The criminal complaint, prosecuted in the Eastern District of Pennsylvania, charged that J&J subsidiary Janssen Pharmaceuticals introduced the antipsychotic drug Risperdal into the interstate market for non-FDA-approved uses targeting the elderly and childr...
Source: Policy and Medicine - Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
More News: Bonuses | Cardiology | Child Development | Children | Conferences | Congestive Heart Failure | Continuing Medical Education | Dementia | Department of Health | Education | Funding | Government | Grants | Health | Health Management | Health Medicine & Bioethics Commentators | Heart | Heart Failure | Hospital Management | Invega | Lawsuits | Legislation | Marketing | Medicaid | Medicare | Men | Nurses | Nursing | Study | Training | Universities & Medical Training | Warnings